HCA Healthcare is trading at $486.74, up 4.62%, after beating Q3 analyst estimates and saying 2026 results should land in the upper half of its guidance range.
- Q3 adjusted earnings were $7.22 per share on revenue of $19.849 billion.
- Management estimated a $400 million pretax uninsured-patient headwind.
- Admissions growth and stronger emergency-room visits supported results.